Takeda AI-Drug Shows Superior Skin Clearance Against Bristol-Myers' Med

기사 요약

Takeda's psoriasis drug zasocitinib outperformed Bristol Myers Squibb's Sotyktu in a Phase 3 study, showing higher skin clearance rates.